Thomas P. Burris, Ph.D., is the Director of the University of Florida Genetics Institute and Professor in Pharmacodynamics in the College of Pharmacy. Prior to joining the UFGI, he was the Alumni Endowed Professor of Pharmacology at the Center for Clinical Pharmacology at Washington University School of Medicine and St. Louis College of Pharmacy. He also was the Vice President for Research at St. Louis College of Pharmacy. Prior to joining the Center for Clinical Pharmacology, Dr. Burris was the William Beaumont, M.D. Professor of Physiology and Chair of the Department of Pharmacology & Physiology at Saint Louis University of School of Medicine. He has also held Professor positions at The Scripps Research Institute and at the Pennington Biomedical Research Center in the LSU system. See more. 

     Dr. Burris is an expert in chemical genomics and pharmacology of nuclear hormone receptors. His research has focused on gene regulation by this class of transcription factors since the early 1990’s. He has expertise in targeting these receptors towards development of drugs to treat a range of human diseases including autoimmune diseases, cancer, metabolic/cardiovascular diseases, and behavioral disorders. He held drug discovery research positions at Johnson & Johnson and Eli Lilly & Company for a decade before returning to academia. 

     He has published over 180 manuscripts including many in prestigious journals such as Nature, Nature Medicine, Nature Immunology, Nature Structure & Molecular Biology, Cancer Cell, Cell Metabolism, Journal of Clinical Investigation and the Proceedings of the National Academy of Sciences. He is an elected fellow of the American Heart Association and the American Association for the Advancement of Science. His lab is currently funded by several NIH grants (NIMH, NIA, NCI, NHLBI & NIAMS) and the Department of Defense. See here for a listing of his scholarly publications.